{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:13:24Z","timestamp":1762125204749,"version":"3.37.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s12010-018-2780-9","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T05:32:10Z","timestamp":1536125530000},"page":"1173-1192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identifying hQC Inhibitors of Alzheimer\u2019s Disease by Effective Customized Pharmacophore-Based Virtual Screening, Molecular Dynamic Simulation, and Binding Free Energy Analysis"],"prefix":"10.1007","volume":"187","author":[{"given":"Weicong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengfu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-2958","authenticated-orcid":false,"given":"Wenjuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangcheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,5]]},"reference":[{"issue":"8","key":"2780_CR1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.5958\/0974-360X.2015.00181.X","volume":"8","author":"S Kayalvili","year":"2015","unstructured":"Kayalvili, S. (2015). Depression is a risk factor for Alzheimer disease-review. Research Journal of Pharmacy and Technology, 8(8), 1056\u20131058. https:\/\/doi.org\/10.5958\/0974-360X.2015.00181.X .","journal-title":"Research Journal of Pharmacy and Technology"},{"issue":"15","key":"2780_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2174\/15680266113139990136","volume":"13","author":"M Anna","year":"2013","unstructured":"Anna, M., Andrea, M., Elena, S., Michela, R., Maria, B. L., Chiara, M., & Vincenzo, T. (2013). Multifunctional tacrine derivatives in Alzheimer\u2019s disease. Current Topics in Medicinal Chemistry, 13(15), 1771\u20131786. https:\/\/doi.org\/10.2174\/15680266113139990136 .","journal-title":"Current Topics in Medicinal Chemistry"},{"issue":"3","key":"2780_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/JCP.0b013e31828b5087","volume":"33","author":"YH Yang","year":"2013","unstructured":"Yang, Y. H., Chen, C. H., Chou, M. C., Li, C. H., Liu, C. K., & Chen, S. H. (2013). Concentration of donepezil to the cognitive response in Alzheimer disease. Journal of Clinical Psychopharmacology, 33(3), 351\u2013355. https:\/\/doi.org\/10.1097\/JCP.0b013e31828b5087 .","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"5","key":"2780_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1586\/14737175.5.5.563","volume":"5","author":"AK Desai","year":"2005","unstructured":"Desai, A. K., & Grossberg, G. T. (2005). Rivastigmine for Alzheimer\u2019s disease. Expert Review of Neurotherapeutics, 5(5), 563\u2013580. https:\/\/doi.org\/10.1586\/14737175.5.5.563 .","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"1","key":"2780_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cercor\/1.1.103","volume":"1","author":"SE Arnold","year":"1991","unstructured":"Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex, 1(1), 103\u2013116. https:\/\/doi.org\/10.1093\/cercor\/1.1.103 .","journal-title":"Cerebral Cortex"},{"issue":"6","key":"2780_CR6","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/BF03327445","volume":"21","author":"F Panza","year":"2009","unstructured":"Panza, F., Solfrizzi, V., Frisardi, V., Imbimbo, B. P., Capurso, C., D\u2019Introno, A., Colacicco, A. M., Seripa, D., Vendemiale, G., Capurso, A., & Pilotto, A. (2009). Beyond the neurotransmitter-focused approach in treating Alzheimer\u2019s disease: drugs targeting \u03b2-amyloid and tau trotein. Aging Clinical and Experimental Research, 21(6), 386\u2013406. https:\/\/doi.org\/10.1007\/BF03327445 .","journal-title":"Aging Clinical and Experimental Research"},{"issue":"1","key":"2780_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/prot.340200106","volume":"20","author":"AC Awad\u00e9","year":"1994","unstructured":"Awad\u00e9, A. C., Cleuziat, P., Gonzal\u00e8S, T., & Robert-Baudouy, J. (1994). Pyrrolidone carboxyl peptidase (Pcp): an enzyme that removes pyroglutamic acid (pGlu) from pGlu-peptides and pGlu-proteins. Proteins, 20(1), 34\u201351. https:\/\/doi.org\/10.1002\/prot.340200106 .","journal-title":"Proteins"},{"issue":"1","key":"2780_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00235695","volume":"38","author":"GN Abraham","year":"1981","unstructured":"Abraham, G. N., & Podell, D. N. (1981). Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Molecular and Cellular Biochemistry, 38(1), 181\u2013190. https:\/\/doi.org\/10.1007\/BF00235695 .","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"36","key":"2780_CR9","doi-asserted-by":"publisher","first-page":"12672","DOI":"10.1021\/bi980497d","volume":"37","author":"E Coillie van","year":"1998","unstructured":"van Coillie, E., Proost, P., van Aelst, I., Struyf, S., Polfliet, M., de Meester, I., Harvey, D. J., van Damme, J., & Opdenakker, G. (1998). Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26\/dipeptidyl peptidase IV. Biochemistry, 37(36), 12672\u201312680. https:\/\/doi.org\/10.1021\/bi980497d .","journal-title":"Biochemistry"},{"issue":"18","key":"2780_CR10","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1016\/S0021-9258(18)47446-7","volume":"262","author":"WH Busby","year":"1987","unstructured":"Busby, W. H., Quackenbush, G. E., Humm, J., Youngblood, W. W., & Kizer, J. S. (1987). An enzyme(s) that converts glutaminyl-peptides into pyroglutamyl-peptides. Presence in pituitary, brain, adrenal medulla, and lymphocytes. Journal of Biological Chemistry, 262(18), 8532\u20138536 http:\/\/www.jbc.org\/content\/262\/18\/8532.short .","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"2780_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1006\/bbrc.2000.3490","volume":"276","author":"Y Harigaya","year":"2000","unstructured":"Harigaya, Y., Saido, T. C., Eckman, C. B., Prada, C. M., Shoji, M., & Younkin, S. G. (2000). Amyloid \u03b2 protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Biochemical and Biophysical Research Communications, 276(2), 422\u2013427. https:\/\/doi.org\/10.1006\/bbrc.2000.3490 .","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"12","key":"2780_CR12","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.biocel.2010.08.015","volume":"42","author":"AP Gunn","year":"2010","unstructured":"Gunn, A. P., Masters, C. L., & Cherny, R. A. (2010). Pyroglutamate-Abeta: role in the natural history of Alzheimer\u2019s disease. International Journal of Biochemistry & Cell Biology, 42(12), 1915\u20131918. https:\/\/doi.org\/10.1016\/j.biocel.2010.08.015 .","journal-title":"International Journal of Biochemistry & Cell Biology"},{"issue":"45","key":"2780_CR13","doi-asserted-by":"publisher","first-page":"38825","DOI":"10.1074\/jbc.R111.288308","volume":"286","author":"S Jawhar","year":"2011","unstructured":"Jawhar, S., Wirths, O., & Bayer, T. A. (2011). Pyroglutamate-A\u03b2: a hatchet man in Alzheimer disease. Journal of Biological Chemistry, 286(45), 38825\u201338832. https:\/\/doi.org\/10.1074\/jbc.R111.288308 .","journal-title":"Journal of Biological Chemistry"},{"issue":"41","key":"2780_CR14","doi-asserted-by":"publisher","first-page":"12393","DOI":"10.1021\/bi0612667","volume":"45","author":"S Schilling","year":"2006","unstructured":"Schilling, S., Lauber, T., Schaupp, M., Manhart, S., Scheel, E., B\u00f6hm, G., & Demuth, H. U. (2006). On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry, 45(41), 12393\u201312399. https:\/\/doi.org\/10.1021\/bi0612667 .","journal-title":"Biochemistry"},{"issue":"29","key":"2780_CR15","doi-asserted-by":"publisher","first-page":"7072","DOI":"10.1021\/bi900818a","volume":"48","author":"D Schlenzig","year":"2009","unstructured":"Schlenzig, D., Manhart, S., Cinar, Y., Kleinschmidt, M., Hause, G., Willbold, D., Funke, S. A., Schilling, S., & Demuth, H. U. (2009). Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry, 48(29), 7072\u20137078. https:\/\/doi.org\/10.1021\/bi900818a .","journal-title":"Biochemistry"},{"key":"2780_CR16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nature11060","volume":"485","author":"JM Nussbaum","year":"2012","unstructured":"Nussbaum, J. M., Schilling, S., Cynis, H., Silva, A., Swanson, E., Wangsanut, T., Tayler, K., Wiltgen, B., Hatami, A., R\u00f6nicke, R., Reymann, K., Hutter-Paier, B., Alexandru, A., Jagla, W., Graubner, S., Glabe, C. G., Demuth, H. U., & Bloom, G. S. (2012). Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated \u03b2-amyloid. Nature, 485, 651\u2013655. https:\/\/doi.org\/10.1038\/nature11060 .","journal-title":"Nature"},{"issue":"36","key":"2780_CR17","doi-asserted-by":"publisher","first-page":"12790","DOI":"10.1523\/JNEUROSCI.1794-11.2011","volume":"31","author":"A Alexandru","year":"2011","unstructured":"Alexandru, A., Jagla, W., Graubner, S., Becker, A., B\u00e4uscher, C., Kohlmann, S., Sedlmeier, R., Raber, K. A., Cynis, H., R\u00f6nicke, R., Reymann, K. G., Petrasch-Parwez, E., Hartlage-R\u00fcbsamen, M., Waniek, A., Rossner, S., Schilling, S., Osmand, A. P., Demuth, H. U., & von H\u00f6rsten, S. (2011). Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated A\u03b2 is induced by pyroglutamate-A\u03b2 formation. Journal of Neuroscience, 31(36), 12790\u201312801. https:\/\/doi.org\/10.1523\/JNEUROSCI.1794-11.2011 .","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"2780_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000353634","volume":"14","author":"G Wu","year":"2014","unstructured":"Wu, G., Miller, R. A., Connolly, B., Marcus, J., Renger, J., & Savage, M. J. (2014). Pyroglutamate-modified amyloid-\u03b2 protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain. Neurodegenerative Diseases, 14(2), 53\u201366. https:\/\/doi.org\/10.1159\/000353634 .","journal-title":"Neurodegenerative Diseases"},{"issue":"1","key":"2780_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1471-4159.2008.05471.x","volume":"237","author":"YM Kuo","year":"1997","unstructured":"Kuo, Y. M., Emmerling, M. R., Woods, A. S., Cotter, R. J., & Roher, A. E. (1997). Isolation, chemical characterization, and quantitation of A\u03b2 3-pyroglutamyl peptide from neuritic plaques and vascular amyloid deposits. Biochemical and Biophysical Research Communications, 237(1), 188\u2013191. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05471.x .","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"2780_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2826.1995.tb00780.x","volume":"7","author":"TM B\u00f6ckers","year":"1995","unstructured":"B\u00f6ckers, T. M., Kreutz, M. R., & Pohl, T. (1995). Glutaminyl-cyclase expression in the bovine\/porcine hypothalamus and pituitary. Journal of Neuroendocrinology, 7(6), 445\u2013453. https:\/\/doi.org\/10.1111\/j.1365-2826.1995.tb00780.x .","journal-title":"Journal of Neuroendocrinology"},{"issue":"50","key":"2780_CR21","doi-asserted-by":"publisher","first-page":"49773","DOI":"10.1074\/jbc.M309077200","volume":"278","author":"S Schilling","year":"2003","unstructured":"Schilling, S., Niestroj, A. J., Rahfeld, J. U., Hoffmann, T., Wermann, M., Zunkel, K., Wasternack, C., & Demuth, H. U. (2003). Identification of human glutaminyl cyclase as a metalloenzyme. Potent inhibition by imidazole derivatives and heterocyclic chelators. Journal of Biological Chemistry, 278(50), 49773\u201349779. https:\/\/doi.org\/10.1074\/jbc.M309077200 .","journal-title":"Journal of Biological Chemistry"},{"key":"2780_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0798-822","volume":"4","author":"C Soto","year":"1998","unstructured":"Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Casta\u00f1o, E. M., & Frangione, B. (1998). \u03b2-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nature Medicine, 4, 822\u2013826. https:\/\/doi.org\/10.1038\/nm0798-822 .","journal-title":"Nature Medicine"},{"issue":"8","key":"2780_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","volume":"9","author":"JA Kanis","year":"1994","unstructured":"Kanis, J. A., Melton, L. J., Christiansen, C., Johnston, C. C., & Khaltaev, N. (1994). The diagnosis of osteoporosis. Journal of Bone and Mineral Research, 9(8), 1137\u20131141. https:\/\/doi.org\/10.1002\/jbmr.5650090802 .","journal-title":"Journal of Bone and Mineral Research"},{"issue":"9","key":"2780_CR24","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham III, C. O., Birnbaum, N. S., Burmester, G. R., Bykerk, V. P., Cohen, M. D., Combe, B., Costenbader, K. H., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Hobbs, K., Huizinga, T. W. J., Kavanaugh, A., Kay, J., Kvien, T. K., Laing, T., Mease, P., M\u00e9nard, H. A., Moreland, L. W., Naden, R. L., Pincus, T., Smolen, J. S., Stanislawska-Biernat, E., Symmons, D., Tak, P. P., Upchurch, K. S., Vencovsk\u00fd, J., Wolfe, F., & Hawker, G. (2010). 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis and Rheumatism, 62(9), 2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584 .","journal-title":"Arthritis and Rheumatism"},{"key":"2780_CR25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., Akerley, W., van den Eertwegh, A. J. M., Lutzky, J., Lorigan, P., Vaubel, J. M., Linette, G. P., Hogg, D., Ottensmeier, C. H., Lebb\u00e9, C., Peschel, C., Quirt, I., Clark, J. I., Wolchok, J. D., Weber, J. S., Tian, J., Yellin, M. J., Nichol, G. M., Hoos, A., & Urba, W. J. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363, 711\u2013723. https:\/\/doi.org\/10.1056\/NEJMoa1003466 .","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"2780_CR26","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1074\/jbc.M110.185819","volume":"286","author":"S Jawhar","year":"2011","unstructured":"Jawhar, S., Wirths, O., Schilling, S., Graubner, S., Demuth, H. U., & Bayer, T. A. (2011). Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A\u03b2 formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. Journal of Biological Chemistry, 286(6), 4454\u20134460. https:\/\/doi.org\/10.1074\/jbc.M110.185819 .","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"2780_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00401-010-0685-y","volume":"120","author":"M Morawski","year":"2010","unstructured":"Morawski, M., Hartlage-R\u00fcbsamen, M., J\u00e4ger, C., Waniek, A., Schilling, S., Schwab, C., McGeer, P. L., Arendt, T., Demuth, H., & Ro\u00dfner, S. (2010). Distinct glutaminyl cyclase expression in edinger-westphal nucleus, locus coeruleus and nucleus basalis meynert contributes to pGlu-A\u03b2 pathology in Alzheimer\u2019s disease. Acta Neuropathologica, 120(2), 195\u2013207. https:\/\/doi.org\/10.1007\/s00401-010-0685-y .","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"2780_CR28","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00401-011-0806-2","volume":"121","author":"M Hartlage-R\u00fcbsamen","year":"2011","unstructured":"Hartlage-R\u00fcbsamen, M., Morawski, M., Waniek, A., J\u00e4ger, C., Zeitschel, U., Koch, B., Cynis, H., Schilling, S., Schliebs, R., Demuth, H., & Ro\u00dfner, S. (2011). Glutaminyl cyclase contributes to the formation of focal and diffuse pyroglutamate (pGlu)-A\u03b2 deposits in hippocampus via distinct cellular mechanisms. Acta Neuropathologica, 121(6), 705\u2013719. https:\/\/doi.org\/10.1007\/s00401-011-0806-2 .","journal-title":"Acta Neuropathologica"},{"issue":"3","key":"2780_CR29","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1471-4159.2008.05471.x","volume":"106","author":"S Schilling","year":"2008","unstructured":"Schilling, S., Appl, T., Hoffmann, T., Cynis, H., Schulz, K., Jagla, W., Friedrich, D., Wermann, M., Buchholz, M., Heiser, U., von Hrsten, S., & Demuth, H. U. (2008). Inhibition of glutaminyl cyclase prevents pGlu-A\u03b2 formation after intracortical\/hippocampal micro-injection in vivo\/in situ. Journal of Neurochemistry, 106(3), 1225\u20131236. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05471.x .","journal-title":"Journal of Neurochemistry"},{"key":"2780_CR30","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nm.1872","volume":"14","author":"S Schilling","year":"2008","unstructured":"Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., Holzer, M., Hutter-Paier, B., Prokesch, M., Windisch, M., Jagla, W., Schlenzig, D., Lindner, C., Rudolph, T., Reuter, G., Cynis, H., Montag, D., Demuth, H. U., & Rossner, S. (2008). Glutaminyl cyclase inhibition attenuates pyroglutamate A\u03b2 and Alzheimer\u2019s disease-like pathology. Nature Medicine, 14, 1106\u20131111. https:\/\/doi.org\/10.1038\/nm.1872 .","journal-title":"Nature Medicine"},{"issue":"1","key":"2780_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1006\/abio.2001.5560","volume":"303","author":"S Schilling","year":"2002","unstructured":"Schilling, S., Hoffmann, T., Wermann, M., Heiser, U., Wasternack, C., & Demuth, H. U. (2002). Continuous spectrometric assays for glutaminyl cyclase activity. Analytical Biochemistry, 303(1), 49\u201356. https:\/\/doi.org\/10.1006\/abio.2001.5560 .","journal-title":"Analytical Biochemistry"},{"issue":"35","key":"2780_CR32","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1021\/bi0260381","volume":"41","author":"S Schilling","year":"2002","unstructured":"Schilling, S., Hoffmann, T., Rosche, F., & Manhart, S. (2002). Heterologous expression and characterization of human glutaminyl cyclase: evidence for a disulfide bond with importance for catalytic activity. Biochemistry, 41(35), 10849\u201310857. https:\/\/doi.org\/10.1021\/bi0260381 .","journal-title":"Biochemistry"},{"issue":"28","key":"2780_CR33","doi-asserted-by":"publisher","first-page":"6280","DOI":"10.1021\/bi200249h","volume":"50","author":"D Ruiz Carrillo","year":"2011","unstructured":"Ruiz Carrillo, D., Koch, B., Parthier, C., Wermann, M., Dambe, T., Buchholz, M., Ludwig, H. H., Heiser, U., Rahfeld, J. U., Stubbs, M. T., Schilling, S., & Demuth, H. U. (2011). Structures of glycosylated mammalian glutaminyl cyclases reveal conformational variability near the active center. Biochemistry, 50(28), 6280\u20136288. https:\/\/doi.org\/10.1021\/bi200249h .","journal-title":"Biochemistry"},{"issue":"2","key":"2780_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1021\/jm050756e","volume":"49","author":"M Buchholz","year":"2006","unstructured":"Buchholz, M., Heiser, U., Schilling, S., Niestroj, A. J., Zunkel, K., & Demuth, H. U. (2006). The first potent inhibitors for human glutaminyl cyclase: synthesis and structure-activity relationship. Journal of Medicinal Chemistry, 49(2), 664\u2013677. https:\/\/doi.org\/10.1021\/jm050756e .","journal-title":"Journal of Medicinal Chemistry"},{"issue":"22","key":"2780_CR35","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1021\/jm900969p","volume":"52","author":"M Buchholz","year":"2009","unstructured":"Buchholz, M., Hamann, A., Aust, S., Brandt, W., B\u00f6hme, L., Hoffmann, T., Schilling, S., Demuth, H. U., & Heiser, U. (2009). Inhibitors for human glutaminyl cyclase by structure based design and bioisosteric replacement. Journal of Medicinal Chemistry, 52(22), 7069\u20137080. https:\/\/doi.org\/10.1021\/jm900969p .","journal-title":"Journal of Medicinal Chemistry"},{"issue":"14","key":"2780_CR36","doi-asserted-by":"publisher","first-page":"12439","DOI":"10.1074\/jbc.M110.208595","volume":"286","author":"KF Huang","year":"2011","unstructured":"Huang, K. F., Liaw, S. S., Huang, W. L., Chia, C. Y., Lo, Y. C., Chen, Y. L., & Wang, A. H. J. (2011). Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding. Journal of Biological Chemistry, 286(14), 12439\u201312449. https:\/\/doi.org\/10.1074\/jbc.M110.208595 .","journal-title":"Journal of Biological Chemistry"},{"issue":"37","key":"2780_CR37","doi-asserted-by":"publisher","first-page":"7383","DOI":"10.1021\/bi300687g","volume":"51","author":"B Koch","year":"2012","unstructured":"Koch, B., Kolenko, P., Buchholz, M., Ruiz Carrillo, D., Parthier, C., Wermann, M., Rahfeld, J. U., Reuter, G., Schilling, S., Stubbs, M. T., & Demuth, H. U. (2012). Crystal structures of glutaminyl cyclases (QCs) from drosophila melanogaster reveal active site conservation between insect and mammalian QCs. Biochemistry, 51(37), 7383\u20137392. https:\/\/doi.org\/10.1021\/bi300687g .","journal-title":"Biochemistry"},{"issue":"6","key":"2780_CR38","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/cbdd.12046","volume":"80","author":"B Koch","year":"2012","unstructured":"Koch, B., Buchholz, M., Wermann, M., Heiser, U., Schilling, S., & Demuth, H. U. (2012). Probing secondary glutaminyl cyclase (QC) inhibitor interactions applying an in silico-modeling\/site-directed muta-genesis approach: implications for drug development. Chemical Biology & Drug Design, 80(6), 937\u2013946. https:\/\/doi.org\/10.1111\/cbdd.12046 .","journal-title":"Chemical Biology & Drug Design"},{"issue":"17","key":"2780_CR39","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1021\/jm4001709","volume":"56","author":"D Ramsbeck","year":"2013","unstructured":"Ramsbeck, D., Buchholz, M., Koch, B., B\u00f6hme, L., Hoffmann, T., Demuth, H. U., & Heiser, U. (2013). Structure\u2013activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold. Journal of Medicinal Chemistry, 56(17), 6613\u20136625. https:\/\/doi.org\/10.1021\/jm4001709 .","journal-title":"Journal of Medicinal Chemistry"},{"issue":"13","key":"2780_CR40","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1016\/j.bmc.2013.04.005","volume":"21","author":"PT Tran","year":"2013","unstructured":"Tran, P. T., Hoang, V. H., Thorat, S. A., Kim, S. E., Ann, J., Chang, Y. J., Nam, D. W., Song, H., Mook-Jung, I., Lee, J., & Lee, J. (2013). Structure-activity relationship of human glutaminyl cyclase inhibitors having an N-(5-methyl-1H-imidazol-1-yl) propyl thiourea template. Bioorganic & Medicinal Chemistry, 21(13), 3821\u20133830. https:\/\/doi.org\/10.1016\/j.bmc.2013.04.005 .","journal-title":"Bioorganic & Medicinal Chemistry"},{"unstructured":"Heiser, U., Ramsbeck, D., Buchholz, M., & Niestroj, A. J. (2015). U.S. Patent No. 9,126,987. Washington, DC: U.S. Patent and Trademark Office.","key":"2780_CR41"},{"issue":"10","key":"2780_CR42","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1016\/10.1016\/j.bmc.2016.03.064","volume":"24","author":"M Li","year":"2016","unstructured":"Li, M., Dong, Y., Yu, X., Zou, Y., Zheng, Y., Bu, X., Quan, J., He, Z., & Wu, H. (2016). Inhibitory effect of flavonoids on human glutaminyl cyclase. Bioorganic & Medicinal Chemistry, 24(10), 2280\u20132286. https:\/\/doi.org\/10.1016\/10.1016\/j.bmc.2016.03.064 .","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"6","key":"2780_CR43","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1021\/acs.jmedchem.7b00098","volume":"60","author":"VH Hoang","year":"2017","unstructured":"Hoang, V. H., Tran, P. T., Cui, M., Ngo, V. T., Ann, J., Park, J., Lee, J., Choi, K., Cho, H., & Kim, H. (2017). Discovery of potent human glutaminyl cyclase inhibitors as anti-Alzheimer's agents based on rational design. Journal of Medicinal Chemistry, 60(6), 2573\u20132590. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00098 .","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"2780_CR44","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.drudis.2010.03.013","volume":"15","author":"SY Yang","year":"2010","unstructured":"Yang, S. Y. (2010). Pharmacophore modeling and applications in drug discovery: challenges and recent advances. Drug Discovery Today, 15(11), 444\u2013450. https:\/\/doi.org\/10.1016\/j.drudis.2010.03.013 .","journal-title":"Drug Discovery Today"},{"key":"2780_CR45","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Waterbeemd van de","year":"2003","unstructured":"van de Waterbeemd, H., & Gifford, E. (2003). ADMET in silico modelling: towards prediction paradise. Nature Reviews Drug Discovery, 2, 192\u2013204. https:\/\/doi.org\/10.1038\/nrd1032 .","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"2780_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin, J. J., & Shoichet, B. K. (2005). ZINC-a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177\u2013182. https:\/\/doi.org\/10.1021\/ci049714+ .","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"14","key":"2780_CR47","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e .","journal-title":"Journal of Medicinal Chemistry"},{"issue":"3","key":"2780_CR48","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair, J., Markt, P., Distinto, S., Wolber, G., & Langer, T. (2008). Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2014what can we learn from earlier mistakes. Journal of Computer-Aided Molecular Design, 22(3), 213\u2013228. https:\/\/doi.org\/10.1007\/s10822-007-9163-6 .","journal-title":"Journal of Computer-Aided Molecular Design"},{"issue":"1","key":"2780_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1), 3\u201325. https:\/\/doi.org\/10.1016\/S0169-409X(96)00423-1 .","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"16","key":"2780_CR50","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. Journal of Computational Chemistry, 30(16), 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 .","journal-title":"Journal of Computational Chemistry"},{"issue":"8","key":"2780_CR51","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1021\/ci500209e","volume":"54","author":"D Santos-Martins","year":"2014","unstructured":"Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014). AutoDock4Zn: an improved autodock force field for small-molecule docking to zinc metalloproteins. Journal of Chemical Information and Modeling, 54(8), 2371\u20132379. https:\/\/doi.org\/10.1021\/ci500209e .","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"1","key":"2780_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","volume":"91","author":"HJC Berendsen","year":"1995","unstructured":"Berendsen, H. J. C., van der Spoel, D., & van Drunen, R. (1995). GROMACS: a message-passing parallel molecular dynamics implementation. Computer Physics Communications, 91(1), 43\u201356. https:\/\/doi.org\/10.1016\/0010-4655(95)00042-E .","journal-title":"Computer Physics Communications"},{"issue":"13","key":"2780_CR53","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF chimera\u2014a visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084 .","journal-title":"Journal of Computational Chemistry"},{"key":"2780_CR54","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen, K., Piana, S., Palmo, K., Maragakis, P., Klepei, J. L., Dror, R. O., & Shaw, D. E. (2010). Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins, 78, 1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711 .","journal-title":"Proteins"},{"issue":"2","key":"2780_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics & Modelling, 25(2), 247\u2013260. https:\/\/doi.org\/10.1016\/j.jmgm.2005.12.005 .","journal-title":"Journal of Molecular Graphics & Modelling"},{"key":"2780_CR56","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AW Sousa da Silva","year":"2012","unstructured":"Sousa da Silva, A. W., & Vranken, W. F. (2012). ACPYPE-AnteChamber PYthon Parser interfacE. BMC Research Notes, 5, 367. https:\/\/doi.org\/10.1186\/1756-0500-5-367 .","journal-title":"BMC Research Notes"},{"issue":"9","key":"2780_CR57","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1021\/ct9001015","volume":"5","author":"DS Cerutti","year":"2009","unstructured":"Cerutti, D. S., Duke, R. E., Darden, T. A., & Lybrand, T. P. (2009). Staggered mesh ewald: an extension of the smooth particle-mesh ewald method adding great versatility. Journal of Chemical Theory and Computation, 5(9), 2322\u20132338. https:\/\/doi.org\/10.1021\/ct9001015 .","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"12","key":"2780_CR58","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO,2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, G. E. M. (1997). LINCS: a linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO,2-H .","journal-title":"Journal of Computational Chemistry"},{"issue":"7","key":"2780_CR59","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R., & Lynn, A. (2014). g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m .","journal-title":"Journal of Chemical Information and Modeling"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-018-2780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12010-018-2780-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-018-2780-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T16:59:37Z","timestamp":1661965177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12010-018-2780-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,5]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2780"],"URL":"https:\/\/doi.org\/10.1007\/s12010-018-2780-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2018,9,5]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}